Table 2:
n | % | PRa | 95% CI | aPRb | 95% CI | ||
---|---|---|---|---|---|---|---|
Retained in Care (N=54,606) | |||||||
No depression | 30463 | 56% | 1.00 | 1.00 | |||
Depression | 24143 | 44% | 1.03 | 1.03–1.04 | 0.98 | 0.97–0.98 | |
No anxiety | 35068 | 64% | 1.00 | 1.00 | |||
Anxiety | 19538 | 36% | 1.03 | 1.02–1.03 | 0.98 | 0.97–0.98 | |
No bipolar disorder | 48943 | 90% | 1.00 | 1.00 | |||
Bipolar disorder | 5663 | 10% | 1.01 | 1.00–1.01 | 1.00 | 1.00–1.01 | |
No schizophrenia | 52304 | 96% | 1.00 | 1.00 | |||
Schizophrenia | 2302 | 4% | 1.01 | 1.00–1.03 | 1.00 | 1.00– 1.01 | |
No MH Disorder | 20724 | 38% | 1.00 | 1.00 | |||
One MH Disorder | 17101 | 31% | 1.02 | 1.02–1.03 | 1.01 | 1.01– 1.01 | |
MH Multimorbidityc | 16781 | 31% | 1.04 | 1.04–1.05 | 1.02 | 1.02– 1.02 | |
Suppressed HIV RNA (≤200 copies/mL) (N=20,231) | |||||||
No depression | 12625 | 62% | 1.00 | 1.00 | |||
Depression | 7606 | 38% | 0.99 | 0.98– 0.99 | 1.01 | 1.00–1.02 | |
No anxiety | 13901 | 69% | 1.00 | 1.00 | |||
Anxiety | 6330 | 31% | 1.00 | 1.00– 1.01 | 1.00 | 1.00–1.01 | |
No bipolar disorder | 18572 | 92% | 1.00 | 1.00 | |||
Bipolar disorder | 1659 | 8% | 0.95 | 0.94–0.97 | 0.98 | 0.98–0.99 | |
No schizophrenia | 19865 | 98% | 1.00 | 1.00 | |||
Schizophrenia | 366 | 2% | 0.96 | 0.93–0.99 | 1.00 | 0.98–1.01 | |
No MH Disorder | 9136 | 45% | 1.00 | 1.00 | |||
One MH Disorder | 6282 | 31% | 0.97 | 0.97–0.98 | 0.99 | 0.99–1.00 | |
MH Multimorbidityc | 4813 | 24% | 0.98 | 0.97–0.99 | 0.99 | 0.99–1.00 |
PR = unadjusted prevalence ratio from a log binomial regression model
aPR = adjusted prevalence ratio from a log binomial regression model, adjusted for decade of age, race/ethnicity (due to small numbers, Asian/PI was collapsed into the other/unknown category), sex, HIV acquisition risk group, and cohort.
Mental health multimorbidity included those with ≥2 MH comorbidities
Values with P<0.05 are bolded.